Approval · Notice of Compliance 4392 · 1996
ETOPOSIDE: Notice of Compliance 4392
Issued August 6, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4392
- Date
- August 6, 1996
- Company
- Bdh Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Antineoplastic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ETOPOSIDE | 02227509 | Cancelled Post Market |
Medicinal ingredients
- ETOPOSIDE 20 MG per ML